18 results

MTV_AMR
Digital

Posted on 10.02.2016

New rapid diagnostic technology will change the way we use antibiotics

With the convergence of electronics, biology and mobile technologies, nowhere is the transformative potential of rapid point of care testing better illustrated than in the challenge to overcome antibiotic resistance. It is widely acknowledged that growing resistance to antibiotics poses a global health threat. The World Health Organisation has said that our ability to treat […]

By Dr. Dale Athey Managing Director, OJ Bio

horizon2020_1
Value

Posted on 15.04.2015

Horizon Prize for better use of antibiotics – Compete, innovate and win €1 million!

The European Commission launched a €1 million prize for a diagnostic test to combat antibiotic resistance. The challenge is to develop a rapid test that will allow healthcare providers to distinguish, at the point of care, between patients with upper respiratory tract infections that require antibiotics and those that can be treated safely without antibiotics. […]

superbugs-approach
Value

Posted on 18.11.2014

How can we approach this era of superbugs and healthcare-associated infections

Today is European Antibiotic Awareness Day. Tackling the era of superbugs should be a team sport. Physicians, companies, foundations and the MedTech industry all want to play their part.

superbugs-physicianview_1
Value

Posted on 29.07.2014

Superbugs: “The physician community needs to get its act together”

The WHO has been raising the ‘threat level’ on this issue progressively each year for the last decade, with individual disease reports highlighting the emerging threat of antimicrobial resistance (AMR). This year’s report however highlights this pandemic like never before, demonstrating it’s global nature and its profound impact on health and economics. I’m a cardiologist and the report speaks to me – actually it screams out loud: “We need to get our act together”.

By Sameer Bansilal Attending Physician in the Mount Sinai Cardiovascular Institute

superbugs-industryview
Value

Posted on 16.07.2014

Superbugs and the role of diagnostics explained

The discussion over superbugs moved center stage earlier this month when British Prime Minister David Cameron launched a global review of the crisis. “If we fail to act, we are looking at an almost unthinkable scenario where antibiotics no longer work and we are cast back into the dark ages of medicine where treatable infections […]

By Jürgen Schulze President of Sysmex EMEA, EDMA President, Chairman of MedTech Europe Board

superbugs-foundationview
Value

Posted on 19.06.2014

Superbugs: Incentivising medtech to deliver solutions

MedTech is transforming the world in which we live; we are healthier and more able than ever before. However, there are still a number of fundamental challenges that we face both locally and globally. The launch of the Longitude Prize 2014, with it’s £10 million prize fund, is seeking solutions to some of these fundamental scientific challenges. Antibiotics resistance, paralysis and dementia are on the shortlist of issues that could reap a £10m research windfall. The MedTech community has a vital and integral role to play, harnessing its power to innovate and accelerate towards the winning solutions!

By Anna Williams Lead Science and Technology Researcher

superbugs-companyview_0
Value

Posted on 18.06.2014

Superbugs: How diagnostics can help doctors reduce over-prescription of antibiotics

A few years ago I was attending a conference on biologics manufacturing and the keynote speaker said their industry was lagging in implementing modern microbiological tools whereas the beer industry was way ahead. I was glad there were no clinical microbiologists in the room!

By Rangarajan Sampath Director of Science & Technology

old keys
Regulation

Posted on 18.03.2011

Effective solutions to prevent 4.1 million healthcare associated infections in Europe

Though we live in countries with well-funded and advanced healthcare settings, we all know that receiving medical treatment inevitably carries risk with it. However, less is known about the procedures in place to minimise the risk of adverse events. Should I be scared to enter a healthcare setting? How do I know if the hospital where I am treated has a procedure in place to minimise risk so that it is not complicated by an infection?

By John Bowis Honorary President, Health First Europe

innovate
Value

Posted on 19.11.2010

Throwing the baby out with the bathwater

Health and Consumer Affairs Commissioner, John Dalli, made a typically balanced speech about his vision for health on the European agenda at a meeting organised by Friends of Europe. The high-level summit entitled ‘An Innovative Healthcare Agenda for Europe’,  was held this week in the magnificent setting of the Bibliotheque Solvay, in the heart of […]

By John Wilkinson Former Chief Executive of Eucomed